BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35885962)

  • 1. Genotype-Phenotype Correlation and Functional Insights for Two Monoallelic
    Amico G; Hemphill WO; Severino M; Moratti C; Pascarella R; Bertamino M; Napoli F; Volpi S; Rosamilia F; Signa S; Perrino F; Zedde M; Ceccherini I; On Behalf Of The Gaslini Stroke Study Group
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nationwide survey of Aicardi-Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study.
    Abe J; Nakamura K; Nishikomori R; Kato M; Mitsuiki N; Izawa K; Awaya T; Kawai T; Yasumi T; Toyoshima I; Hasegawa K; Ohshima Y; Hiragi T; Sasahara Y; Suzuki Y; Kikuchi M; Osaka H; Ohya T; Ninomiya S; Fujikawa S; Akasaka M; Iwata N; Kawakita A; Funatsuka M; Shintaku H; Ohara O; Ichinose H; Heike T
    Rheumatology (Oxford); 2014 Mar; 53(3):448-58. PubMed ID: 24300241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome.
    Fye JM; Orebaugh CD; Coffin SR; Hollis T; Perrino FW
    J Biol Chem; 2011 Sep; 286(37):32373-82. PubMed ID: 21808053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity.
    Orebaugh CD; Fye JM; Harvey S; Hollis T; Perrino FW
    J Biol Chem; 2011 Nov; 286(46):40246-54. PubMed ID: 21937424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Arg-62 residues of the TREX1 exonuclease act across the dimer interface contributing to catalysis in the opposing protomers.
    Fye JM; Coffin SR; Orebaugh CD; Hollis T; Perrino FW
    J Biol Chem; 2014 Apr; 289(16):11556-11565. PubMed ID: 24616097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring TREX1 and TREX2 exonuclease activities.
    Hemphill WO; Perrino FW
    Methods Enzymol; 2019; 625():109-133. PubMed ID: 31455522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic variability of a TREX1 variant in Aicardi-Goutieres type 1 patients from the Indian subcontinent.
    Abraham SSC; Yoganathan S; Koshy B; Oommen SP; Simon A; Mathai S; Korula S; Mathew L; Sathishkumar D; Jasper A; George R; Danda S
    Eur J Med Genet; 2021 Sep; 64(9):104291. PubMed ID: 34303877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model.
    Xiao N; Wei J; Xu S; Du H; Huang M; Zhang S; Ye W; Sun L; Chen Q
    J Autoimmun; 2019 Jun; 100():84-94. PubMed ID: 30872080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aicardi-Goutières syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion.
    Li P; Du J; Goodier JL; Hou J; Kang J; Kazazian HH; Zhao K; Yu XF
    Nucleic Acids Res; 2017 May; 45(8):4619-4631. PubMed ID: 28334850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aicardi-Goutières syndrome.
    Crow YJ
    Handb Clin Neurol; 2013; 113():1629-35. PubMed ID: 23622384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.
    Lehtinen DA; Harvey S; Mulcahy MJ; Hollis T; Perrino FW
    J Biol Chem; 2008 Nov; 283(46):31649-56. PubMed ID: 18805785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Goutières Syndrome.
    Gray EE; Treuting PM; Woodward JJ; Stetson DB
    J Immunol; 2015 Sep; 195(5):1939-43. PubMed ID: 26223655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.
    Rice GI; Forte GM; Szynkiewicz M; Chase DS; Aeby A; Abdel-Hamid MS; Ackroyd S; Allcock R; Bailey KM; Balottin U; Barnerias C; Bernard G; Bodemer C; Botella MP; Cereda C; Chandler KE; Dabydeen L; Dale RC; De Laet C; De Goede CG; Del Toro M; Effat L; Enamorado NN; Fazzi E; Gener B; Haldre M; Lin JP; Livingston JH; Lourenco CM; Marques W; Oades P; Peterson P; Rasmussen M; Roubertie A; Schmidt JL; Shalev SA; Simon R; Spiegel R; Swoboda KJ; Temtamy SA; Vassallo G; Vilain CN; Vogt J; Wermenbol V; Whitehouse WP; Soler D; Olivieri I; Orcesi S; Aglan MS; Zaki MS; Abdel-Salam GM; Vanderver A; Kisand K; Rozenberg F; Lebon P; Crow YJ
    Lancet Neurol; 2013 Dec; 12(12):1159-69. PubMed ID: 24183309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome.
    Rice G; Newman WG; Dean J; Patrick T; Parmar R; Flintoff K; Robins P; Harvey S; Hollis T; O'Hara A; Herrick AL; Bowden AP; Perrino FW; Lindahl T; Barnes DE; Crow YJ
    Am J Hum Genet; 2007 Apr; 80(4):811-5. PubMed ID: 17357087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing.
    Zhou W; Mohr L; Maciejowski J; Kranzusch PJ
    Mol Cell; 2021 Feb; 81(4):739-755.e7. PubMed ID: 33606975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease.
    Bailey SL; Harvey S; Perrino FW; Hollis T
    DNA Repair (Amst); 2012 Jan; 11(1):65-73. PubMed ID: 22071149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus.
    Crow YJ; Hayward BE; Parmar R; Robins P; Leitch A; Ali M; Black DN; van Bokhoven H; Brunner HG; Hamel BC; Corry PC; Cowan FM; Frints SG; Klepper J; Livingston JH; Lynch SA; Massey RF; Meritet JF; Michaud JL; Ponsot G; Voit T; Lebon P; Bonthron DT; Jackson AP; Barnes DE; Lindahl T
    Nat Genet; 2006 Aug; 38(8):917-20. PubMed ID: 16845398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1.
    Crow YJ; Chase DS; Lowenstein Schmidt J; Szynkiewicz M; Forte GM; Gornall HL; Oojageer A; Anderson B; Pizzino A; Helman G; Abdel-Hamid MS; Abdel-Salam GM; Ackroyd S; Aeby A; Agosta G; Albin C; Allon-Shalev S; Arellano M; Ariaudo G; Aswani V; Babul-Hirji R; Baildam EM; Bahi-Buisson N; Bailey KM; Barnerias C; Barth M; Battini R; Beresford MW; Bernard G; Bianchi M; Billette de Villemeur T; Blair EM; Bloom M; Burlina AB; Carpanelli ML; Carvalho DR; Castro-Gago M; Cavallini A; Cereda C; Chandler KE; Chitayat DA; Collins AE; Sierra Corcoles C; Cordeiro NJ; Crichiutti G; Dabydeen L; Dale RC; D'Arrigo S; De Goede CG; De Laet C; De Waele LM; Denzler I; Desguerre I; Devriendt K; Di Rocco M; Fahey MC; Fazzi E; Ferrie CD; Figueiredo A; Gener B; Goizet C; Gowrinathan NR; Gowrishankar K; Hanrahan D; Isidor B; Kara B; Khan N; King MD; Kirk EP; Kumar R; Lagae L; Landrieu P; Lauffer H; Laugel V; La Piana R; Lim MJ; Lin JP; Linnankivi T; Mackay MT; Marom DR; Marques Lourenço C; McKee SA; Moroni I; Morton JE; Moutard ML; Murray K; Nabbout R; Nampoothiri S; Nunez-Enamorado N; Oades PJ; Olivieri I; Ostergaard JR; Pérez-Dueñas B; Prendiville JS; Ramesh V; Rasmussen M; Régal L; Ricci F; Rio M; Rodriguez D; Roubertie A; Salvatici E; Segers KA; Sinha GP; Soler D; Spiegel R; Stödberg TI; Straussberg R; Swoboda KJ; Suri M; Tacke U; Tan TY; te Water Naude J; Wee Teik K; Thomas MM; Till M; Tonduti D; Valente EM; Van Coster RN; van der Knaap MS; Vassallo G; Vijzelaar R; Vogt J; Wallace GB; Wassmer E; Webb HJ; Whitehouse WP; Whitney RN; Zaki MS; Zuberi SM; Livingston JH; Rozenberg F; Lebon P; Vanderver A; Orcesi S; Rice GI
    Am J Med Genet A; 2015 Feb; 167A(2):296-312. PubMed ID: 25604658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TREX1 C-terminal region controls cellular localization through ubiquitination.
    Orebaugh CD; Fye JM; Harvey S; Hollis T; Wilkinson JC; Perrino FW
    J Biol Chem; 2013 Oct; 288(40):28881-92. PubMed ID: 23979357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREX1 p.A129fs and p.Y305C variants in a large multi-ethnic cohort of CADASIL-like unrelated patients.
    Foddis M; Blumenau S; Holtgrewe M; Paquette K; Westra K; Alonso I; Macario MDC; Morgadinho AS; Velon AG; Santo G; Santana I; Mönkäre S; Kuuluvainen L; Schleutker J; Pöyhönen M; Myllykangas L; Pavlovic A; Kostic V; Dobricic V; Lohmann E; Hanagasi H; Santos M; Guven G; Bilgic B; Bras J; Beule D; Dirnagl U; Guerreiro R; Sassi C
    Neurobiol Aging; 2023 Mar; 123():208-215. PubMed ID: 36586737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.